PRELUDE CAPITAL MANAGEMENT, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$44,000
+2100.0%
4,900
+1675.4%
0.00%
Q4 2019$2,000
-33.3%
276
-14.8%
0.00%
Q3 2019$3,000
-25.0%
324
-10.7%
0.00%
Q2 2019$4,000
-55.6%
363
-59.1%
0.00%
Q1 2019$9,000
-98.8%
888
-97.9%
0.00%
-100.0%
Q3 2018$725,000
+19.4%
42,7590.0%0.04%
+10.5%
Q2 2018$607,000
+15075.0%
42,759
+19514.2%
0.04%
Q1 2018$4,000
-60.0%
218
-62.9%
0.00%
-100.0%
Q4 2017$10,000
-50.0%
588
-56.4%
0.00%
-50.0%
Q3 2017$20,000
+5.3%
1,350
-37.6%
0.00%0.0%
Q2 2017$19,000
-5.0%
2,163
-38.5%
0.00%
-33.3%
Q3 2015$20,000
-60.0%
3,517
-21.8%
0.00%
-57.1%
Q2 2015$50,000
+13.6%
4,500
+60.7%
0.01%
+16.7%
Q1 2015$44,000
-60.0%
2,800
-61.1%
0.01%
-62.5%
Q4 2014$110,000
+189.5%
7,200
+166.7%
0.02%
+166.7%
Q4 2013$38,000
+35.7%
2,7000.0%0.01%
+20.0%
Q3 2013$28,000
-47.2%
2,700
-60.2%
0.01%
-54.5%
Q2 2013$53,0006,7760.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders